Pre-Activity Test Question Title * 1. According to the Centers for Disease Control and Prevention 2019 list of priority pathogens, which of the following bacteria is considered an urgent threat? MDR P. aeruginosa Carbapenem-resistant Enterobacteriaceae MRSA Drug-resistant S. pneumoniae Question Title * 2. According to SENTRY Program data, which of the following pathogens has shown little to no increase in prevalence between 1997-2000 and 2013-2016? ESBL-producing Enterobacteriaceae MDR P. aeruginosa MDR Enterobacteriaceae Carbapenem-resistant Enterobacteriaceae Question Title * 3. Which of the following carbapenemases is commonly found in North America and is not classified as a metallo-beta-lactamase? IMP KPC NDM VIM Question Title * 4. Which of the following newer antimicrobials exhibits the most potent activity against MDR P. aeruginosa? Ceftolozane-tazobactam Meropenem-vaborbactam Plazomicin Eravacycline Question Title * 5. Newer beta-lactam/beta-lactamase inhibitor agents can provide activity against all of the following resistance types except: AmpC KPC Metallo-beta-lactamase OXA-48 Question Title * 6. Which of the following antimicrobials would be preferred for the treatment of urinary tract infection caused by ESBL-producing E. coli? Meropenem Meropenem-vaborbactam Cefiderocol Amikacin plus colistin Question Title * 7. A 63-year-old man who has been hospitalized and intubated for 5 days following myocardial infarction develops nosocomial pneumonia. Rapid molecular diagnostics is performed on a BAL sample and indicates a KPC-producing Gram-negative organism. Which of the following would be the most appropriate antimicrobial agent? Piperacillin-tazobactam Ceftazidime-avibactam Doripenem Colistin plus tigecycline Question Title * 8. Which of the following is not an anticipated goal of rapid diagnostic testing? Reduction in hospital length of stay Prevention of unnecessary drug toxicity Increase usage of broad-spectrum therapy Prevention of resistance emergence Done